Secondary Prevention: Beta-Blockers and Antiplatelets

Two trials on post-MI beta-blockers (mixed results by EF) and an individual-patient meta-analysis favoring clopidogrel over aspirin for long-term secondary prevention without increased bleeding.

Transcript

Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app